Literature DB >> 15373913

Stimulation of toll-like receptor 2 in mononuclear cells from HIV-infected patients induces chemokine responses: possible pathogenic consequences.

L Heggelund1, J K Damås, A Yndestad, A M Holm, F Mūller, E Lien, T Espevik, P Aukrust, S S Frøland.   

Abstract

Toll-like receptor 2 (TLR2) stimulation in monocytes may contribute to enhanced inflammation and viral replication in HIV infection. In the present study we examined if TLR2 stimulation could modulate chemokine responses in peripheral blood mononuclear cells (PBMC) from HIV-infected patients and healthy controls. Our main findings were, with similar qualitative patterns in both healthy controls and HIV-infected patients: (1) TLR2 stimulation induced up-regulation of several chemokines at the mRNA level as well as increased protein levels of macrophage inflammatory protein (MIP)-1alpha, interleukin (IL)-8 and regulated on activation, normal T cell expressed and secreted (RANTES); (2) TLR2 stimulation induced enhanced protein expression of CCR5 (a receptor for MIP-1alpha and RANTES) on monocytes; (3) In vitro stimulation with RANTES induced release of MIP-1alpha, MCP-1, IL-8 and interferon-gamma from PBMC. While increased levels of beta-chemokines possibly have antiviral effects, TLR2 stimulation may also promote a chemokine-driven inflammatory loop, potentially contributing to the immunopathogenesis of HIV infection.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15373913      PMCID: PMC1809198          DOI: 10.1111/j.1365-2249.2004.02595.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  29 in total

Review 1.  RANTES: a versatile and controversial chemokine.

Authors:  V Appay; S L Rowland-Jones
Journal:  Trends Immunol       Date:  2001-02       Impact factor: 16.687

Review 2.  Chemokines as natural HIV antagonists.

Authors:  Alessia Verani; Paolo Lusso
Journal:  Curr Mol Med       Date:  2002-12       Impact factor: 2.222

Review 3.  Chemokine induction by HIV-1: recruitment to the cause.

Authors:  Todd A Reinhart
Journal:  Trends Immunol       Date:  2003-07       Impact factor: 16.687

4.  RANTES and MIP-1beta mRNA expression in human peripheral blood mononuclear cells: transcript quantification using NASBA technology.

Authors:  J W Romano; R N Shurtliff; E M Lee; R Cornelison; S Than; M H Kaplan; C C Ginocchio
Journal:  J Immunol Methods       Date:  2001-09-01       Impact factor: 2.303

Review 5.  Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease.

Authors:  E A Berger; P M Murphy; J M Farber
Journal:  Annu Rev Immunol       Date:  1999       Impact factor: 28.527

Review 6.  Contribution of immune activation to the pathogenesis and transmission of human immunodeficiency virus type 1 infection.

Authors:  S D Lawn; S T Butera; T M Folks
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

7.  Increased expression of the inflammatory chemokine CXC chemokine ligand 9/monokine induced by interferon-gamma in lymphoid tissues of rhesus macaques during simian immunodeficiency virus infection and acquired immunodeficiency syndrome.

Authors:  Todd A Reinhart; Beth A Fallert; Melanie E Pfeifer; Sonali Sanghavi; Saverio Capuano; Premeela Rajakumar; Michael Murphey-Corb; Richard Day; Craig L Fuller; Todd M Schaefer
Journal:  Blood       Date:  2002-05-01       Impact factor: 22.113

8.  HIV-1 Tat reprograms immature dendritic cells to express chemoattractants for activated T cells and macrophages.

Authors:  Elena Izmailova; Frederic M N Bertley; Qian Huang; Norbert Makori; Christopher J Miller; Richard A Young; Anna Aldovini
Journal:  Nat Med       Date:  2003-01-21       Impact factor: 53.440

Review 9.  Toll-like receptor signaling and regulation of cytokine gene expression in the immune system.

Authors:  Keiko Ozato; Hideki Tsujimura; Tomohiko Tamura
Journal:  Biotechniques       Date:  2002-10       Impact factor: 1.993

Review 10.  Toll-like receptors.

Authors:  Kiyoshi Takeda; Tsuneyasu Kaisho; Shizuo Akira
Journal:  Annu Rev Immunol       Date:  2001-12-19       Impact factor: 28.527

View more
  11 in total

1.  HIV type 1 infection up-regulates TLR2 and TLR4 expression and function in vivo and in vitro.

Authors:  Juan C Hernández; Mario Stevenson; Eicke Latz; Silvio Urcuqui-Inchima
Journal:  AIDS Res Hum Retroviruses       Date:  2012-03-12       Impact factor: 2.205

2.  A role for TLR signaling during B cell activation in antiretroviral-treated HIV individuals.

Authors:  Basile Siewe; Ali Keshavarzian; Audrey French; Patricia Demarais; Alan Landay
Journal:  AIDS Res Hum Retroviruses       Date:  2013-08-16       Impact factor: 2.205

3.  Isolation, Transfection, and Culture of Primary Human Monocytes.

Authors:  Karlie Plaisance-Bonstaff; Celeste Faia; Dorota Wyczechowska; Duane Jeansonne; Cecilia Vittori; Francesca Peruzzi
Journal:  J Vis Exp       Date:  2019-12-16       Impact factor: 1.355

4.  Failure of TLR4-driven NF-kappa B activation to stimulate virus replication in models of HIV type 1 activation.

Authors:  Sushila K Nordone; Glicerio A Ignacio; Lishan Su; Gregory D Sempowski; Douglas T Golenbock; Liwu Li; Gregg A Dean
Journal:  AIDS Res Hum Retroviruses       Date:  2007-11       Impact factor: 2.205

Review 5.  Mechanism(s) involved in opioid drug abuse modulation of HAND.

Authors:  Raini Dutta; Sabita Roy
Journal:  Curr HIV Res       Date:  2012-07       Impact factor: 1.581

6.  Constitutive gene expression in monocytes from chronic HIV-1 infection overlaps with acute Toll-like receptor induced monocyte activation profiles.

Authors:  Bethsebah Gekonge; Malavika S Giri; Andrew V Kossenkov; Michael Nebozyhn; Malik Yousef; Karam Mounzer; Louise Showe; Luis J Montaner
Journal:  PLoS One       Date:  2012-07-18       Impact factor: 3.240

7.  Chronic morphine and HIV-1 Tat promote differential central nervous system trafficking of CD3+ and Ly6C+ immune cells in a murine Streptococcus pneumoniae infection model.

Authors:  Raini Dutta; Sabita Roy
Journal:  J Neuroinflammation       Date:  2015-06-20       Impact factor: 8.322

Review 8.  Insights into Soluble Toll-Like Receptor 2 as a Downregulator of Virally Induced Inflammation.

Authors:  Bethany M Henrick; Xiao-Dan Yao; Ameer Y Taha; J Bruce German; Kenneth Lee Rosenthal
Journal:  Front Immunol       Date:  2016-08-02       Impact factor: 7.561

9.  Toll-like receptor-2 exacerbates murine acute viral hepatitis.

Authors:  Christian Bleau; Mélanie Burnette; Aveline Filliol; Claire Piquet-Pellorce; Michel Samson; Lucie Lamontagne
Journal:  Immunology       Date:  2016-08-10       Impact factor: 7.397

10.  Stimulation of PBMC and Monocyte-Derived Macrophages via Toll-Like Receptor Activates Innate Immune Pathways in HIV-Infected Patients on Virally Suppressive Combination Antiretroviral Therapy.

Authors:  Esther Merlini; Camilla Tincati; Mara Biasin; Irma Saulle; Federico Angelo Cazzaniga; Antonella d'Arminio Monforte; Amedeo J Cappione; Jennifer Snyder-Cappione; Mario Clerici; Giulia Carla Marchetti
Journal:  Front Immunol       Date:  2016-12-19       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.